187 related articles for article (PubMed ID: 16254105)
1. Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Palmer AA; Zhang XD; Thompson JF; Bron LP; Hersey P
J Clin Pathol; 2005 Nov; 58(11):1163-9. PubMed ID: 16254105
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
Jørgensen K; Davidson B; Flørenes VA
Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
4. Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome.
Jørgensen K; Holm R; Maelandsmo GM; Flørenes VA
Clin Cancer Res; 2003 Nov; 9(14):5325-31. PubMed ID: 14614017
[TBL] [Abstract][Full Text] [Related]
5. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.
Mirmohammadsadegh A; Mota R; Gustrau A; Hassan M; Nambiar S; Marini A; Bojar H; Tannapfel A; Hengge UR
J Invest Dermatol; 2007 Sep; 127(9):2207-15. PubMed ID: 17508026
[TBL] [Abstract][Full Text] [Related]
6. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
8. In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation.
Venesio T; Chiorino G; Balsamo A; Zaccagna A; Petti C; Scatolini M; Pisacane A; Sarotto I; Picciotto F; Risio M
Mod Pathol; 2008 Jun; 21(6):716-26. PubMed ID: 18408659
[TBL] [Abstract][Full Text] [Related]
9. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
10. BRAF somatic mutations in malignant melanoma and melanocytic naevi.
Thomas NE
Melanoma Res; 2006 Apr; 16(2):97-103. PubMed ID: 16567964
[TBL] [Abstract][Full Text] [Related]
11. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Screaton G; Hersey P
Hum Pathol; 2006 Oct; 37(10):1286-94. PubMed ID: 16949935
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
Kuźbicki L; Sarnecka A; Chwirot BW
Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-actived protein kinase activation is an early event in melanoma progression.
Cohen C; Zavala-Pompa A; Sequeira JH; Shoji M; Sexton DG; Cotsonis G; Cerimele F; Govindarajan B; Macaron N; Arbiser JL
Clin Cancer Res; 2002 Dec; 8(12):3728-33. PubMed ID: 12473582
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi.
Uribe P; Andrade L; Gonzalez S
J Invest Dermatol; 2006 Jan; 126(1):161-6. PubMed ID: 16417232
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of DUSP6 phosphatase stimulate tumourigenesis in a molecularly distinct melanoma subtype.
Li W; Song L; Ritchie AM; Melton DW
Pigment Cell Melanoma Res; 2012 Mar; 25(2):188-99. PubMed ID: 22171919
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.
Massi D; De Nisi MC; Franchi A; Mourmouras V; Baroni G; Panelos J; Santucci M; Miracco C
Mod Pathol; 2009 Jan; 22(1):21-30. PubMed ID: 18660796
[TBL] [Abstract][Full Text] [Related]
18. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
Gao L; Feng Y; Bowers R; Becker-Hapak M; Gardner J; Council L; Linette G; Zhao H; Cornelius LA
Cancer Res; 2006 Aug; 66(16):7880-8. PubMed ID: 16912161
[TBL] [Abstract][Full Text] [Related]
19. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.
Li Y; Yu P; Zou Y; Cai W; Sun W; Han N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4257-4265. PubMed ID: 31736361
[TBL] [Abstract][Full Text] [Related]
20. Activation of the extracellular signal-regulated kinases signaling pathway in squamous cell carcinoma of the skin.
Zhang X; Makino T; Muchemwa FC; Lin T; Wakasugi S; Egawa K; Ihn H
Biosci Trends; 2007 Dec; 1(3):156-60. PubMed ID: 20103886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]